Does ICATIBANT Cause Product packaging issue? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product packaging issue have been filed in association with ICATIBANT (Icatibant). This represents 0.1% of all adverse event reports for ICATIBANT.
5
Reports of Product packaging issue with ICATIBANT
0.1%
of all ICATIBANT reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product packaging issue From ICATIBANT?
Of the 5 reports, 2 (40.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Product packaging issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ICATIBANT. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ICATIBANT Cause?
Hereditary angioedema (2,221)
Drug ineffective (506)
Product dose omission issue (421)
Weight decreased (386)
Weight increased (367)
Product use issue (332)
Injection site pain (331)
Inappropriate schedule of product administration (305)
Headache (294)
Malaise (262)
What Other Drugs Cause Product packaging issue?
ACETAMINOPHEN (448)
LOPERAMIDE (351)
DIMETHICONE\LOPERAMIDE (348)
USTEKINUMAB (221)
FENTANYL (200)
MINOXIDIL (173)
CETIRIZINE (166)
ESTRADIOL (163)
GOLIMUMAB (95)
CYCLOSPORINE (93)
Which ICATIBANT Alternatives Have Lower Product packaging issue Risk?
ICATIBANT vs ICHTHAMMOL\ZINC
ICATIBANT vs ICLUSIG
ICATIBANT vs ICODEXTRIN
ICATIBANT vs ICOSAPENT
ICATIBANT vs ICOSAPENT ETHYL